AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Evolution of long-acting drugs and changing perceptions in diabetes treatment
In the past, short-acting drugs required multiple injections per day, leading to a push for long-acting drugs. Increasing the drug dosage resulted in unprecedented body weight loss. The first GLP drug in 2005 targeted type 2 diabetes, but diabetes may not have been as prevalent or well-handled as it is today.